Ashton Thomas Private Wealth LLC purchased a new stake in Everus (NYSE:ECG – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 3,776 shares of the company’s stock, valued at approximately $248,000.
A number of other institutional investors and hedge funds also recently bought and sold shares of ECG. SRS Capital Advisors Inc. acquired a new stake in Everus in the 4th quarter valued at about $26,000. Principal Securities Inc. purchased a new stake in Everus during the fourth quarter valued at about $27,000. HighMark Wealth Management LLC purchased a new stake in Everus during the fourth quarter valued at about $28,000. Crews Bank & Trust purchased a new stake in Everus during the fourth quarter valued at about $29,000. Finally, Mendota Financial Group LLC purchased a new stake in Everus during the fourth quarter valued at about $36,000.
Analysts Set New Price Targets
A number of research firms have commented on ECG. Wolfe Research began coverage on shares of Everus in a research note on Tuesday, December 3rd. They set a “peer perform” rating for the company. Oppenheimer upped their price objective on shares of Everus from $70.00 to $80.00 and gave the company an “outperform” rating in a research note on Tuesday, January 7th. Finally, Stifel Nicolaus reduced their price objective on shares of Everus from $85.00 to $67.00 and set a “buy” rating for the company in a research note on Thursday, February 13th.
Everus Trading Down 1.3 %
Shares of ECG opened at $37.72 on Wednesday. Everus has a fifty-two week low of $37.18 and a fifty-two week high of $77.93. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.50 and a current ratio of 1.58. The firm has a 50-day simple moving average of $59.51.
Everus (NYSE:ECG – Get Free Report) last issued its earnings results on Tuesday, February 11th. The company reported $0.67 earnings per share for the quarter, missing analysts’ consensus estimates of $0.73 by ($0.06). Sell-side analysts predict that Everus will post 2.49 EPS for the current fiscal year.
Insider Buying and Selling
In other news, CFO Maximillian J. Marcy acquired 1,300 shares of the company’s stock in a transaction that occurred on Tuesday, February 25th. The shares were purchased at an average price of $38.99 per share, for a total transaction of $50,687.00. Following the completion of the acquisition, the chief financial officer now owns 5,508 shares of the company’s stock, valued at approximately $214,756.92. This represents a 30.89 % increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Rocca Michael Della acquired 1,050 shares of the company’s stock in a transaction that occurred on Tuesday, February 18th. The stock was purchased at an average price of $47.56 per share, for a total transaction of $49,938.00. Following the acquisition, the director now directly owns 2,027 shares of the company’s stock, valued at $96,404.12. The trade was a 107.47 % increase in their position. The disclosure for this purchase can be found here. Over the last quarter, insiders have bought 3,750 shares of company stock worth $153,853.
Everus Company Profile
Everus Construction Group is providing a full spectrum of construction services through its electrical and mechanical and transmission and distribution specialty contracting services principally in United States. Its specialty contracting services are provided to utility, transportation, commercial, industrial, institutional, renewable and other customers.
Featured Stories
- Five stocks we like better than Everus
- 3 Best Fintech Stocks for a Portfolio Boost
- NVIDIA Stock Remains Stunningly Undervalued—Here’s Why
- Using the MarketBeat Stock Split Calculator
- Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy
- What Do S&P 500 Stocks Tell Investors About the Market?
- U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave
Receive News & Ratings for Everus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Everus and related companies with MarketBeat.com's FREE daily email newsletter.